Skip to content
Search

Latest Stories

Terms of reference agreed for Pharmacy Representation Review

The Pharmacy Review Steering Committee has agreed the terms of reference and the plan of action for the independent review into the PSNC and LPC representation and support for contractors on its first meeting on December 19, 2019.

Chaired by David Wright, Professor of Pharmacy Practice from the School of Pharmacy at the University of East Anglia, the review will look at the roles and structures underpinning the Pharmaceutical Services Negotiating Committee (PSNC) and Local Pharmaceutical Committees (LPC).


“This is the first-ever review of the PSNC and LPC infrastructure and therefore we are somewhat in unchartered waters. I am therefore delighted that the first PRSC meeting was incredibly positive, we have agreed a way forward for the review and a way of working together,” said Professor Wright.

The review aims to provide recommendations which will optimise PSNC and LPC contractor representation. It will also suggest methods to support and ensure that the national network structure is working as efficiently for contractors as it can and is fit for the future.

Separate focus groups will be held in Leeds, Leicester, London and Taunton with LPC and contractor representatives this month to develop national survey tools for distribution in February.

The review team includes Dr Michael Twigg and Dr Linda Birt, both from the University of East Anglia, and Dr Hannah Family of the University of Bristol.

The final report of the review is expected by April 2020.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less